The year 2019 comes to an end with significant advancements in precision medicine, genetics, genomics, CRISPR technology, liquid biopsy, and immunotherapy. Highlights and notable news included various technological...read more
Latest blogs
BC Platforms Aims to Advance Clinical Decision-Making by Enhancing Clinical Data with Genomics Information
This month’s “Company Spotlight” provides a closer look at the Finnish-Swiss company BC Platforms, a genomic data management and analysis solutions provider, working to revolutionize drug development and to enable...read more
An interview with Michael Snyder, Stanford W. Ascherman Professor and Chair, Department of Genetics & Director, Center for Genomics and Personalized Medicine
The following is an interview I recently conducted for the PMWC Intl. team with Dr. Mike Snyder, Professor of Genetics at Stanford University, and in essence is a repost of the original interview that can be found on...read more
Mike Pellini, Section 32: “I hope we will find a way where the payers and the healthcare industry will work much more closely together to generate the data that will ultimately be useful in answering difficult, cost-based decisions.”
The following is an interview I recently conducted for the PMWC Intl. team with Dr. Mike Pellini, Managing Partner of Section 32 (former CEO of Foundation Medicine), and in essence is a repost of the original interview...read more
Othram Aims to Overcome DNA Sequencing Challenges to Solve Forensic Crime Cases
This month’s “Company Spotlight” takes a closer look at Othram Inc which applies the power of modern sequencing technology and genomics to forensics. David Mittelman, Chief Executive Officer of Othram, discussed with us...read more
Immunotherapy and the Basis of Neoantigen Biology: Part II Cancer Immunotherapies
Last month’s Immunotherapy and the Basis of Neonatigen Biology blog post focused on neoantigens along with some facets of immunology and cancer that are interrelated. We described in detail how neoantigens and other...read more
Immunotherapy and the Basis of Neoantigen Biology: Part I Neoantigens
Since the dawn of the 20th century it was thought that the immune system could ultimately play a role in the treatment of cancers (Wirth and Kunhel, 2017). There has been a resurgence of interest in the last decades in...read more
